As stated in the CY 2025 OPPS/ASC final rule with comment period (89 FR 93932 through 93938), given the unique nature of these therapies, we do not believe they function as integral, ancillary, supportive, dependent, or adjunctive to any of the current primary C-APC services
HealthiCare's personalized tirzepatide follows the same model as personalized semaglutide - same physician-prescribed, US-pharmacy-filled pathway, dramatically different price than the brand-name version
Science 368 , 779782 (2020)
Roughly 5 to 8% of patients in clinical trials discontinued due to side effects
Liver function tests annually , or more frequently if baseline abnormalities exist or if patients develop symptoms suggesting hepatobiliary disease
controlled trial data is what separates signal from noise